The invention relates to polysulfated glycosides of formula (I), the pharmaceutically acceptable salts thereof, as well as the pharmaceutical compositions containing these compounds as active ingredients. Furthermore the invention provides a method of preventing, treating or alleviating the symptoms of acute and chronic inflammatory disorders of the airways of mammals—including asthma and asthma-related pathologies.
The invention relates to polysulfated glycosides of formula (I), the pharmaceutically acceptable salts thereof, as well as the pharmaceutical compositions containing these compounds as active ingredients. Furthermore the invention provides a method of preventing, treating or alleviating the symptoms of acute and chronic inflammatory disorders of the airways of mammals—including asthma and asthma-related pathologies.
US7902158B2
申请人:——
公开号:US7902158B2
公开(公告)日:2011-03-08
US8987216B2
申请人:——
公开号:US8987216B2
公开(公告)日:2015-03-24
[EN] POLYSULFATED GLYCOSIDES AND SALTS THEREOF<br/>[FR] GLYCOSIDES POLYSULFATES ET SELS DE CEUX-CI